Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Partial purification and properties of a plasminogen activator from human erythrocytes
M. Semar, … , L. Skoza, A. J. Johnson
M. Semar, … , L. Skoza, A. J. Johnson
Published October 1, 1969
Citation Information: J Clin Invest. 1969;48(10):1777-1785. https://doi.org/10.1172/JCI106144.
View: Text | PDF
Research Article

Partial purification and properties of a plasminogen activator from human erythrocytes

  • Text
  • PDF
Abstract

The lysis time of euglobulin clots made with whole blood (plasma and red cells) was very much shorter than that of clots made with plasma alone, indicating a fibrinolytic component in red cells. A plasminogen activator was found in the stroma-free hemolysate, and proteolytic activity was found in the stromal fraction. The plasminogen activator, purified by using diethylaminoethyl-cellulose (DEAE-cellulose) in a batch procedure followed by column chromatography, was called erythrokinase (EK). On preliminary characterization, EK appears to activate human and bovine plasminogen in a manner similar to urokinase (UK), as determined by fibrinolytic and caseinolytic assays. The two enzymes can be separated by DEAE chromatography and acrylamide-gel electrophoresis, however, and they hydrolyze acetyl-L-lysine methyl ester and benzoyl arginine methyl ester at different rates.

Authors

M. Semar, L. Skoza, A. J. Johnson

×

Total citations by year

Year: 2011 2001 1997 1984 1983 1981 1979 1976 1974 1973 1972 1971 Total
Citations: 1 1 1 1 3 2 1 1 6 2 4 1 24
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (24)

Title and authors Publication Year
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee
Annual Reports in Medicinal Chemistry Volume 46 2011
Fibrinolytics and Antifibrinolytics
F Bachmann
2001
Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator
M Yamada, T Horiuchi, T Oribe, S Yamamoto, I Sugie, P A Gentry
Veterinary Research Communications 1997
Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase
FM Booyse, G Osikowicz, S Feder, J Scheinbuks
The Journal of biological chemistry 1984
Identification of the plasminogen activator(s) produced by the transformed liver cell line, SK-HEP-1
GH Barlow, SL Firestone, KC Robbins
Thrombosis Research 1983
The Physiology of Hemostasis
D Ogston
1983
Purification and characterization of the biliary plasminogen activator bilokinase
S Oshiba, T Ariga
The Journal of biological chemistry 1983
Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity
SM Camiolo, G Markus, JL Evers, H Hobika, JL Depasquale, S Beckley, JP Grimaldi
International Journal of Cancer 1981
Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells
FM Booyse, J Scheinbuks, J Radek, G Osikowicz, S Feder, AJ Quarfoot
Thrombosis Research 1981
Neutral proteases from human and ovine erythrocyte membranes
GK Scott, TB Kee
International Journal of Biochemistry 1979
Relationship between cell surface protease activity and doubling time in various normal and transformed cells
VB Hatcher, MS Wertheim, CY Rhee, G Tsien, PG Burk
Biochimica et Biophysica Acta (BBA) - General Subjects 1976
Increased protease levels in transformed cells: A casein overlay assay for the detection of plasminogen activator production
AR Goldberg
Cell 1974
Some properties of the tissue plasminogen activator from the pig heart
A Hijikata, K Fujimoto, H Kitaguchi, S Okamoto
Thrombosis Research 1974
Interaction between red cell membranes and fibrinogen
M Murray, DE Rearick
Thrombosis Research 1974
The Red Blood Cell
GJ Brewer
The Red Blood Cell 1974
Blood
WH Crosby
Blood 1974
Proteinase Inhibitors
H Fritz, H Tschesche, LJ Greene, E Truscheit
1974
The Influence of Haemoglobin on the Fibrinolytic Enzyme System
D Ogston, RJ Herbert
Scandinavian Journal of Haematology 1973
Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: Host cell activation of serum plasminogen
SG Lazarowitz, AR Goldberg, PW Choppin
Virology 1973
Increase in Fibrinogen and Fibrin-Related Antigen in Human Serum Due to In Vitro Lysis of Fibrin by Thrombin
C Merskey, AJ Johnson, P Lalezari
Journal of Clinical Investigation 1972
Clinical experience with brinase
EP Frisch
Journal of clinical pathology 1972
Disseminated intravascular coagulation (DIC): An approach
RW Colman, SJ Robboy, JD Minna
The American Journal of Medicine 1972
The Physiology of Fibrinolysis
T Astrup, S Thorsen
Medical Clinics of North America 1972
11. ON THE ORIGIN OF THE PROTEOLYTIC ACTIVITY RESPONSIBLE FOR THE RELEASE OF FIBRINOGEN-FIBRIN RELATED ANTIGEN IN VITRO*
AJ Johnson, C Merskey
Scandinavian Journal of Haematology 1971

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts